Care coordination, equity can eliminate disparities for nonwhite patients with DLBCLDecember 8, 2019DLBCL
Adding polatuzumab extends survival in relapsed/refractory DLBCLNovember 16, 2019B Cell LymphomaDLBCL
Armored CAR T cells elicit responses in NHL patientsNovember 12, 2019B Cell LymphomaDLBCLFollicular Lymphoma
CAR T-cell therapy found safe, effective for HIV-associated lymphomaSeptember 20, 2019B Cell LymphomaDLBCL
Chemo-free combo gets high response rate in relapsed or refractory DLBCLJuly 23, 2019B Cell LymphomaDLBCL
CAR T-cell therapy less effective in transformed follicular lymphomaJuly 22, 2019Follicular LymphomaB Cell LymphomaDLBCL
Flavopiridol elicits poor response in mantle cell lymphoma, DLBCLJuly 18, 2019Mantle Cell LymphomaB Cell LymphomaDLBCL
